Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Los Angeles, California 90095


Purpose:

The objective of this trial is to evaluate the safety and efficacy of intravitreal microplasmin 125ug dose in subjects wiht focal vitreomacular adhesion.


Criteria:

Inclusion Criteria: - Subjects with symptomatic focal vitreomacular adhesion are eligible for the study. Exclusion Criteria: - Subjects with ocular abnormalities or prior treatments that would potentially interfere with the evaluation of safety and efficacy of study drug are excluded from participation. - Subjects who are pregnant or of child-bearing potential not utilizing an acceptable form of contraception. Acceptable methods of birth control include intrauterine device, oral, implanted, or injected contraceptives, and barrier methods with spermicide. - Subjects who, in the investigators view, will not complete all visits and investigations. - Subjects who have participated in an investigational drug trial within the past 30 days. - Subjects who have previously participated in this trial.


NCT ID:

NCT00781859


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Los Angeles, California 90095
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.